Guhan Pharmaceutical Group Co., Ltd. (SHE:000590)

China flag China · Delayed Price · Currency is CNY
11.16
+0.06 (0.54%)
Apr 30, 2026, 3:04 PM CST
28.13%
Market Cap 2.67B
Revenue (ttm) 344.12M
Net Income (ttm) -41.07M
Shares Out 239.47M
EPS (ttm) -0.17
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 3,746,672
Average Volume 4,469,136
Open 10.77
Previous Close 11.10
Day's Range 10.77 - 11.27
52-Week Range 8.64 - 15.25
Beta 0.35
RSI 45.44
Earnings Date Apr 30, 2026

About SHE:000590

Guhan Pharmaceutical Group Co., Ltd., together with its subsidiaries, manufactures and sells traditional Chinese medicines, chemical drugs, and health food under the Guhan brand in China. It operates through the Pharmaceutical and Health Product Manufacturing and Sales Business, Active Pharmaceutical Ingredient (API) Manufacturing and Sales Business, and Other Business segments. The company offers prescription and over-the-counter drugs, such as tonics, cardiovascular drugs, children's nutritional supplements, cold and flu remedies, and heat-cl... [Read more]

Sector Healthcare
Founded 1956
Employees 1,064
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 000590
Full Company Profile

Financial Performance

In 2025, SHE:000590's revenue was 337.67 million, a decrease of -1.61% compared to the previous year's 343.21 million. Losses were -50.52 million, -59.74% less than in 2024.

Financial Statements

News

There is no news available yet.